Repeal for Resilience: Did Over-Regulation Cause America's COVID Testing Delay? Online Event
Some of the most helpful policy responses to the coronavirus pandemic loosen rather than impose restrictions. Many of the regulations that are being scrapped to fight COVID-19 were #NeverNeeded in the first place. Please join CEI for an online discussion about how deregulation offers a swift, effective response to both the current crisis and long-term economic renewal.
More than a month after the first COVID-19 case was detected in the United States, health officials had administered fewer than 500 diagnostic tests. That delay put the American health care system on a back foot and contributed to the novel coronavirus’s rampant spread. Even now, as we conduct more than 500,000 tests daily, America is still suffering a backlog of the critical testing needed to determine who is infected, who should be isolated, and how many may now be immune.
Our public health system failed, but this is not merely a failure of leadership. Much of the problem can be traced to regulatory choices and policy decisions made long before the emergence of COVID-19. Join us as our panel of health policy experts discusses the origins and causes of coronavirus testing delays and some possible solutions, and as we examine the role additional testing will have to play as we re-open the American economy.
Wednesday, July 15, 2020, 12:00 pm – 1:00 pm EDT
Roger D. Klein, Faculty Fellow, Arizona State University Center for Law, Science & Innovation, and Chief Medical Officer, Omniseq
Joel M. Zinberg, Senior Fellow, Competitive Enterprise Institute, and Associate Clinical Professor of Surgery, Mount Sinai Hospital Icahn School of Medicine
Gregory Conko, Senior Fellow, Competitive Enterprise Institute
Questions? Email email@example.com
Roger D. Klein is a Faculty Fellow at the Center for Law, Science & Innovation at the Sandra Day O'Connor College of Law at Arizona State University and Chief Medical Officer of Omniseq. Previously, Roger was Medical Director of Molecular Pathology at the Cleveland Clinic. He is a former advisor to HHS, FDA. CDC, and CMS, and has served as Chair of the Professional Relations Committee and the Solid Tumors Subdivision at the Association for Molecular Oncology. Roger is licensed to practice medicine in Ohio and Florida. Additionally, he is licensed to practice law in the District of Columbia and Ohio. Roger completed molecular genetic pathology training at Mayo Medical School following post-graduate medical training in laboratory medicine, medical microbiology and virology, and molecular genetics at Yale University School of Medicine. He obtained his J.D. from Yale Law School.
Joel M. Zinberg is a Senior Fellow with the Competitive Enterprise Institute, and he recently completed two years as General Counsel and Senior Economist at the Council of Economic Advisers in the Executive Office of the President. Zinberg practiced general and oncologic surgery in New York for nearly 30 years at the Mount Sinai Hospital and Icahn School of Medicine where he is an Associate Clinical Professor of Surgery. He has been involved with health policy issues and the interaction between law and medicine for his entire career, and he taught for 10 years at the Columbia University Law School as a Lecturer in Law. He served for many years on the New York State Board of Professional Medical Conduct and on Mount Sinai's Ethics Committee and Institutional Review Board. He is past President and Trustee of the New York County Medical Society. Between 2015 and 2017 he was a Visiting Scholar at the American Enterprise Institute. Zinberg has written for publications as varied as the Journal of the American Medical Association, the Bulletin of the American College of Surgeons, The Wall Street Journal, City Journal, and law reviews. He received his J.D. from the Yale Law School, his M.D. from the Columbia University College of Physicians and Surgeons and his B.A. in economics with High Honors, Phi Beta Kappa, from Swarthmore College.
Gregory Conko is a Senior Fellow at the Competitive Enterprise Institute. His research focuses on health care, food and drug regulation, agriculture and agricultural trade, and nutrition and public health. He rejoined the CEI staff in November 2019 after serving as Deputy Director of the George Mason University Law & Economics Center. Earlier in his career, he was a Research Associate at the Capital Research Center, and later a Senior Fellow and then Executive Director of CEI. He was also a co-founder and member of the board of directors of the AgBioWorld Foundation in Auburn, Alabama. Conko is the author or co-author of numerous books, studies, and articles, and his book, The Frankenfood Myth: How Protest and Politics Threaten the Biotech Revolution, co-authored with Henry I. Miller, was named one of the 25 best books of 2004 by Barron’s. Conko is also a Senior Affiliated Scholar with the Mercatus Center at George Mason University and a member of the American Council on Science and Health’s Board of Scientific and Policy Advisors. He received a J.D. degree magna cum laude from the George Mason University School of Law and a B.A. in political science and history from American University.